The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment

Journal of Substance Abuse Treatment

Volumn 38, Issue SUPPL. 1, 2010, Pages

  Tai, Betty ^a   Straus, Michele M ^a   Liu, David ^a   Sparenborg, Steven ^a   Jackson, Ron ^b   McCarty, Dennis ^c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Evergreen Treatment Services   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Clinical Trials Network; Drug abuse treatment; Research

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; METHADONE; METHYLPHENIDATE;

ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; COCAINE DEPENDENCE; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; DETOXIFICATION; DOSAGE SCHEDULE COMPARISON; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; EXERCISE; FAMILY THERAPY; HEALTH CARE COST; HUMAN; INTERDISCIPLINARY COMMUNICATION; INTERVIEW; MOTIVATION; OPIATE ADDICTION; PRIORITY JOURNAL; REIMBURSEMENT; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; EVIDENCE-BASED MEDICINE; HUMANS; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); SUBSTANCE-RELATED DISORDERS; TRANSLATIONAL RESEARCH; UNITED STATES;

EID: 77950199781     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.01.011     Document Type: Article

References (66)

1. Albright L., Hamilton J.A., Kellogg S., Killeen T., Petry N.M., Rosenfeld J., et al. Promoting Awareness of Motivational Incentives. Addiction Technology Transfer Center Network: 2006, http://www.attcnetwork.org/explore/priorityareas/science/blendinginitiative/pami/.
2. Amass L., Ling W., Freese T.E., Reiber C., Annon J.J., Cohen A.J., et al. Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience. American Journal on Addictions 2004, 13(Suppl 1):542-566.
3. Ball S.A., Martino S., Nich C., Frankforter T.L., Van Horn D., Crits-Christoph P., et al. Site matters: Multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. Journal of Consulting and Clinical Psychology 2007, 75:556-567.
4. Bickel W.K., Amass L., Higgins S.T., Badger G.J., Esch R.A. Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology 1997, 65:803-810.
5. Brigham G.S., Amass L., Winhusen T., Harrer J.M., Pelt A. Using buprenorphine short-term taper to facilitate early treatment engagement. Journal of Substance Abuse Treatment 2007, 32:349-356.
6. Brown L.S., Kritz S., Goldsmith R.J., Bini E.J., Robinson J., Alderson D., et al. Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs. Public Health Reports 2007, 122:441-451.
7. Budney A.J., Higgins S.T., Radonovich K.J., Novy P.L. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting and Clinical Psychology 2000, 68:1051-1061.
8. Calsyn D.A., Hatch-Maillette M., Tross S., Doyle S.R., Crits-Christoph P., Song Y.S., et al. Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. Journal of Substance Abuse Treatment 2009, 37:138-150.
9. Carroll K.M., Ball S.A., Nich C., Martino S., Frankforter T.L., Farentinos C., et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence 2006, 81:301-312.
10. Carroll K.M., Farentinos C., Ball S.A., Crits-Christoph P., Libby B., Morgenstern J., et al. MET meets the real world: Design issues and clinical strategies in the Clinical Trials Network. Journal of Substance Abuse Treatment 2002, 23:73-80.
11. Collins E.D., Horton T., Reinke K., Amass L., Nunes E.V. Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation. Journal of Substance Abuse Treatment 2007, 32:167-175.
12. CTN Dissemination Library Publications Catalog 2009, Retrieved June 15, 2009, from The CTN Dissemination Library Website. http://ctndisseminationlibrary.org/catalog.pdf.
13. Department of Health and Human Services Protection of Human Subjects 2005, Retrieved June 15, 2009, from HHS Office for Human Research Protections (OHRP) Website. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm.
14. Dougherty D., Conway P.H. The "3T's" road map to transform US health care: The "how" of high-quality care. Journal of the American Medical Association 2008, 299:2319-2321.
15. Ducharme L.J., Knudsen H.K., Roman P.M., Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 2007, 32:321-329.
16. Fiellin D.A. Treatment of adolescent opioid dependence: No quick fix. Journal of the American Medical Association 2008, 300:2057-2059.
17. Forman R., Crits-Christoph P., Kaynak O., Worley M., Hantula D.A., Kulaga A., et al. A feasibility study of a Web-based performance improvement system for substance abuse treatment providers. Journal of Substance Abuse Treatment 2007, 33:363-371.
18. Garber A.M., Tunis S.R. Does comparative-effectiveness research threaten personalized medicine?. New England Journal of Medicine 2009, 360:1925-1927.
19. Glasgow R.E., Davidson K.W., Dobkin P.L., Ockene J., Spring B. Practical behavioral trials to advance evidence-based behavioral medicine. Annals of Behavioral Medicine 2006, 31:5-13.
20. Glasgow R.E., Magid D.J., Beck A., Ritzwoller D., Estabrooks P.A. Practical clinical trials for translating research to practice: Design and measurement recommendations. Medical Care 2005, 43:551-557.
21. Green L.W., Glasgow R.E. Evaluating the relevance, generalization, and applicability of research: Issues in external validation and translation methodology. Evaluation & the Health Professions 2006, 29:126-153.
22. Hanson G.R., Leshner A.I., Tai B. Putting drug abuse research to use in real-life settings. Journal of Substance Abuse Treatment 2002, 23:69-70.
23. Hien D.A., Wells E.A., Jiang H., Suarez-Morales L., Campbell A.N., Cohen L.R., et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. Journal of Consulting and Clinical Psychology 2009, 77:607-619.
24. Higgins S.T., Alessi S.M., Dantona R.L. Voucher-based incentives: A substance abuse treatment innovation. Addictive Behaviors 2002, 27:887-910.
25. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Donham R., Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry 1994, 51:568-576.
26. Higgins S.T., Silverman K., Heil S.H. Contingency management in substance abuse treatment 2008, Guilford Press, New York.
27. Hohmann A.A., Shear M.K. Community based intervention research: Coping with the noise of real life in study design. American Journal of Psychiatry 2002, 159:201-207.
28. Horowitz C.R., Robinson M., Seifer S. Community-based participatory research from the margin to the mainstream: Are researchers prepared?. Circulation 2009, 119:2633-2642.
29. Hubbard R.L., Leimberger J.D., Haynes L., Patkar A.A., Holter J., Liepman M., et al. Telephone Enhancement of Long-term Engagement (TELE) in continuing care for substance abuse treatment: A NIDA Clinical Trials Network (CTN) study. American Journal on Addictions 2007, 16:495-502.
30. Institute of Medicine Learning what works best: The nations need for evidence on comparative effectiveness in health care 2007, Retrieved June 15, 2009, from. http://www.iom.edu/Object.File/Master/43/390/Comparative%20Effectiveness%20White%20Paper%20(F).pdf.
31. Institute of Medicine Evidence-based medicine and the changing nature of health care: 2007 IOM annual meeting summary 2008, The National Academies Press, Washington, DC.
32. Institute of Medicine Initial national priorities for comparative effectiveness research 2009, The National Academies Press, Washington, DC.
33. Inventory and Evaluation of Clinical Research Networks IECRN Project Report 2006, Retrieved June 15, 2009, from Networks for Clinical Research. https://www.clinicalresearchnetworks.org/4f.asp#_Report.
34. Kellogg S., Burns M., Coleman P., Stitzer M.L., Wale J.B., Kreek M.J. Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service. Journal of Substance Abuse Treatment 2005, 28:57-65.
35. Kilbourne A.M., Neumann M.S., Pincus H.A., Bauer M.S., Stall R. Implementing evidence-based interventions in health care: Application of the replicating effective programs framework. Implementation Science 2007, 2. Retrieved February 22, 2010 from the NCBI website:. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248206/pdf/1748-5908-2-42.pdf.
36. Knapp W.P., Soares B., Farrell M., Silva de Lima M. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews 2007, Retrieved February 22, 2010 from the Cochrane Database of Systematic Review website. http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003023/pdf_fs.html.
37. Lamb S., Greenlick M.R., McCarty D. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment 1998, National Academy Press, Washington, DC.
38. Ling W., Amass L., Shoptaw S., Annon J.J., Hillhouse M., Babcock D., et al. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 2005, 100:1090-1100.
39. Ling W., Hillhouse M., Domier C., Doraimani G., Hunter J., Thomas C., et al. Buprenorphine tapering schedule and illicit opioid use. Addiction 2009, 104:256-265.
40. Martino S., Ball S.A., Gallon S.L., Hall D., Garcia M., Ceperich S., et al. Motivational interviewing assessment: Supervisory tools for enhancing proficiency 2006, Northwest Frontier Addiction Technology Transfer Center, Oregon Health and Science University, Salem, OR.
41. Martins R.K., McNeil D.W. Review of motivational interviewing in promoting health behaviors. Clinical Psychology Review 2009, 29:283-293.
42. McCarty D., Fuller B., Kaskutas L.A., Wendt W.W., Nunes E.V., Miller M., et al. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug and Alcohol Dependence 2008, 92:200-207.
43. McLellan T. Revisiting the past for a look toward future research: A final editorial. Journal of Substance Abuse Treatment 2009, 36:352-354.
44. Miller W.R., Sorensen J.L., Selzer J.A., Brigham G.S. Disseminating evidence-based practices in substance abuse treatment: A review with suggestions. Journal of Substance Abuse Treatment 2006, 31:25-39.
45. National Drug Abuse Treatment Clinical Trials Network Network Organization/By-Laws 2008, Retrieved June 15, 2009, from CTN Website. http://www.nida.nih.gov/CTN/pdf/CTNByLaws.pdf.
46. National Drug Abuse Treatment Clinical Trials Network Network Organization/Nodes 2008, Retrieved June 15, 2009, from CTN Website. http://www.drugabuse.gov/CTN/node.html.
47. NIDA-SAMHSA-ATTC Blending Team The science of treatment: Dissemination of research-based drug addiction treatment findings 2007, NIDA/SAMHSA-ATTC Blending Initiative, Rockville, MD.
48. NIH Roadmap Initiative NIH Roadmap for medical research 2008, Retrieved June 15, 2009, from Re-engineering the Clinical Research Enterprise. http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp.
49. Olmstead T.A., Sindelar J.L., Petry N.M. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug and Alcohol Dependence 2007, 87:175-182.
50. Pan J.J., Nahm M., Wakim P., Cushing C., Poole L., Tai B., et al. A centralized informatics infrastructure for the National Institute on Drug Abuse Clinical Trials Network. Clinical Trials 2009, 6:67-75.
51. Peirce J.M., Petry N.M., Stitzer M.L., Blaine J., Kellogg S., Satterfield F., et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry 2006, 63:201-208.
52. Petry N.M. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug and Alcohol Dependence 2000, 58:9-25.
53. Petry N.M., Kolodner K.B., Li R., Peirce J.M., Roll J.M., Stitzer M.L., et al. Prize-based contingency management does not increase gambling. Drug and Alcohol Dependence 2006, 83:269-273.
54. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes and they will come: Contingency management for treatment of alcohol dependence. Journal of Consulting and Clinical Psychology 2000, 68:250-257.
55. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A National Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry 2005, 62:1148-1156.
56. Reid M.S., Fallon B., Sonne S., Flammino F., Nunes E.V., Jiang H., et al. Smoking cessation treatment in community-based substance abuse rehabilitation programs. Journal of Substance Abuse Treatment 2008, 35:68-77.
57. Rogers E.M. Diffusion of innovations 2003, Free Press, New York. 5th ed.
58. Rosa C.L., Campbell A.N.C., Kleppinger C., Sampson R., Tyson C., Mamay-Gentilin S. Quality assurance of research protocols conducted in the community: The National Institute on Drug Abuse Clinical Trials Network experience. Clinical Trials 2009, 6:151-161.
59. Saxon A.J., McCarty D. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacology & Therapeutics 2005, 108:119-128.
60. Sindelar J.L., Olmstead T.A., Peirce J.M. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007, 102:1463-1471.
61. Substance Abuse and Mental Health Services Administration Public Law No. 106-310, Title XXXV 2000, Retrieved June 15, 2009, from Drug Addiction Treatment Act of 2000. http://www.buprenorphine.samhsa.gov/fulllaw.html.
62. Tross S., Campbell A.N., Cohen L.R., Calsyn D., Pavlicova M., Miele G.M., et al. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of a NIDA Clinical Trials Network Trial. Journal of Acquired Immune Deficiency Syndromes 2008, 48:581-589.
63. Tunis S.R., Stryer D.B., Clancy C.M. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association 2003, 290:1624-1632.
64. Westfall J.M., Mold J., Fagnan L. Practice-based research-"Blue Highways" on the NIH roadmap. Journal of the American Medical Association 2007, 297:403-406.
65. Winhusen T., Kropp F., Babcock D., Hague D., Erickson S.J., Renz C., et al. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. Journal of Substance Abuse Treatment 2008, 35:161-173.
66. Woody G.E., Poole S.A., Subramaniam G., Dugosh K., Bogenschutz M., Abbott P., et al. Extended vs. short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial. Journal of the American Medical Association 2008, 300:2003-2011.